Periostin as a novel biomarker of cardiovascular disease: A systematic evidence landscape of preclinical and clinical studies.
Md AzharuddinMohammad AdilPinaki GhoshPrem KapurManju SharmaPublished in: Journal of evidence-based medicine (2020)
The evidence of current review support potential role of periostin in the pathophysiology of CVD. However, scarcity of data regarding the clinical use of periostin levels in the current management of CVDs further creates room for the future investigation. Therefore, further studies warrant to clarify its potential role, if any, as a novel cardiac biomarker.